NCT02779283 2020-05-26Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaOHSU Knight Cancer InstitutePhase 1 Completed7 enrolled
NCT00705874 2016-07-21Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaProgen PharmaceuticalsPhase 1 Completed172 enrolled 13 charts
NCT00392496 2014-05-15Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 2 Completed19 enrolled 4 charts
NCT00398112 2014-05-14Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNational Cancer Institute (NCI)Phase 2 Completed18 enrolled 9 charts
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled